Literature DB >> 27565732

IL-8 interacts with metadherin promoting proliferation and migration in gastric cancer.

Wenfeng Li1, Shuangming Lin1, Wenhuan Li2, Weijun Wang2, Xueming Li3, Dongbo Xu4.   

Abstract

It has been reported that IL-8 was involved in the promotion of invasion of Gastric Cancer (GC), however the underlying mechanism by which IL-8 was observed to be able to promote invasion remains unknown. Here, in our study, IL-8 was shown to be significantly up-regulated in GC compared with paired normal control tissues whose expression was markedly associated with inferior overall prognosis; and IL-8 was displayed to be capable of directly interacting with metadherin (MTDH), which in turn can up-regulate IL-8 expression. Blockage of IL-8/MTDH using specific mono-antibody can abolish the invasion IL-8 mediated. Taken together, our results may provide a novel explanation of working mechanism of IL-8 in the invasion of GC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; IL-8; Invasion; MTDH; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27565732     DOI: 10.1016/j.bbrc.2016.08.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation.

Authors:  Rongquan He; Li Gao; Jie Ma; Zhigang Peng; Shengsheng Zhou; Lihua Yang; Zhenbo Feng; Yiwu Dang; Gang Chen
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

2.  The Bacterial Species Campylobacter jejuni Induce Diverse Innate Immune Responses in Human and Avian Intestinal Epithelial Cells.

Authors:  Daniel A John; Lisa K Williams; Venkateswarlu Kanamarlapudi; Thomas J Humphrey; Thomas S Wilkinson
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

3.  Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.

Authors:  Yaqiong Du; Bojian Jiang; Shuzheng Song; Guoqing Pei; Xiaochun Ni; Jugang Wu; Shoulian Wang; Zhengyuan Wang; Jiwei Yu
Journal:  Int J Oncol       Date:  2017-05-17       Impact factor: 5.650

4.  Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8-Mediated MAPK/ERK Signaling.

Authors:  Pengwei Yan; Huanfeng Zhu; Li Yin; Lijun Wang; Peng Xie; Jinjun Ye; Xuesong Jiang; Xia He
Journal:  Transl Oncol       Date:  2018-03-21       Impact factor: 4.243

Review 5.  Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.

Authors:  Zhi-Jian Han; Yang-Bing Li; Lu-Xi Yang; Hui-Juan Cheng; Xin Liu; Hao Chen
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

6.  Expressivity of Interleukin-8 and Gastric Cancer Prognosis Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Zhenzhen Wang; Yuhan Hou; Zhen Yao; Yanyan Zhan; Wenyue Chen; Yulong Liu
Journal:  Dose Response       Date:  2021-09-12       Impact factor: 2.658

7.  Interleukin-8 Regulates the Autophagy and Apoptosis in Gastric Cancer Cells via Regulating PI3K/Akt Signaling Pathway.

Authors:  Liang Yu; Guoqiang Zhou; Zhiliang Shi; Jian Guo; Shengyuan Yu; Cheng Yu; Chenglong Shen
Journal:  Dis Markers       Date:  2022-08-11       Impact factor: 3.464

8.  Identification of the lncRNA-miRNA-mRNA network associated with gastric cancer via integrated bioinformatics analysis.

Authors:  Xiao-Yu Ma; Yu Ma; Huan Zhou; Hui-Jing Zhang; Ming-Jun Sun
Journal:  Oncol Lett       Date:  2019-09-25       Impact factor: 2.967

9.  Paracrine interleukin-8 affects mesenchymal stem cells through the Akt pathway and enhances human umbilical vein endothelial cell proliferation and migration.

Authors:  Lulu Wang; Yongtao Li; Xiaodong Zhang; Na Liu; Shiyang Shen; Shizhu Sun; Yang Jiang; Penghui Li; Haifeng Jin; Lei Shen
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.